Thomas Pap
- Rheumatology top 0.1%
- Osteoarthritis Treatment and Mechanisms 56
- Rheumatoid Arthritis Research and Therapies 42
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 32
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 23
- Immunology top 2%
- Oncology top 1%
-
- Bone Metabolism and Diseases 20
-
- Viral Infections and Immunology Research 19
-
- Proteoglycans and glycosaminoglycans research 14
-
- Inflammatory mediators and NSAID effects 13
- Co-authors
- Steffen GayJessica BertrandAdelheid Korb‐PapRenate E. GayUlf Müller‐LadnerOliver DistlerIngo H. TarnerR E Gay
- Journals
- Annals of the Rheumatic Diseases (39 papers)Osteoarthritis and Cartilage (20 papers)Arthritis Research & Therapy (13 papers)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Thomas Pap
191 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Rheumatology 3.6k
- Immunology and Allergy 686
- Cancer Research 1.2k
- Immunology 1.4k
- Oncology 1.7k
Countries citing papers authored by Thomas Pap
This map shows the geographic impact of Thomas Pap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pap more than expected).
Fields of papers citing papers by Thomas Pap
This network shows the impact of papers produced by Thomas Pap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pap. The network helps show where Thomas Pap may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Pap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2020 | 66 | |
| 5 | 2020 | 53 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 16 | |
| 8 | 2017 | 29 | |
| 9 | 2016 | 20 | |
| 10 | 2016 | 60 | |
| 11 | 2015 | 1 | |
| 12 | MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS | 2014 | 2 |
| 13 | 2013 | 49 | |
| 14 | 2010 | 29 | |
| 15 | 2007 | 110 | |
| 16 | 2007 | 225 | |
| 17 | 2005 | 2 | |
| 18 | The inhibitor of differentiation-2 (Id-2) induced by hypoxia promotes bone de radation in rheumatoid arthritis (RA) | 2004 | 1 |
| 19 | 2003 | 179 | |
| 20 | 2002 | 13 |
About Thomas Pap
Thomas Pap is a scholar working on Rheumatology, Immunology and Allergy, Cancer Research, Equine and Oncology, having authored 199 papers that have together received 8.1k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (56 papers), Rheumatoid Arthritis Research and Therapies (42 papers), Cell Adhesion Molecules Research (32 papers), Protease and Inhibitor Mechanisms (23 papers), Bone Metabolism and Diseases (20 papers), Viral Infections and Immunology Research (19 papers), Proteoglycans and glycosaminoglycans research (14 papers) and Inflammatory mediators and NSAID effects (13 papers). The work is most often cited by research in Rheumatology (3.6k citations), Immunology and Allergy (686 citations), Cancer Research (1.2k citations), Immunology (1.4k citations) and Oncology (1.7k citations). Thomas Pap has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Steffen Gay, Jessica Bertrand, Adelheid Korb‐Pap, Renate E. Gay, Ulf Müller‐Ladner, Oliver Distler, Ingo H. Tarner, R E Gay, Adelheid Korb and Lars C Huber. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage, Arthritis Research & Therapy, Nature Medicine and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.